Skip to main content
. Author manuscript; available in PMC: 2018 Nov 5.
Published in final edited form as: JAMA Pediatr. 2018 Feb 1;172(2):143–153. doi: 10.1001/jamapediatrics.2017.4043

Table 1.

Patient and Cardiac Arrest Characteristics by Hypotension Groupa

Any Hypotension at 0–6 h
Characteristic Overall (N = 292) No (n = 214) Yes (n = 78) P Value
Age at randomization, median (IQR), mo 23.0(5.0–105.0) 25.5 (7.0–96.0) 14.0 (3.0–145.0) .18b
Male, No. (%) 194 (66.4) 138 (64.5) 56(71.8) .24c
Race, No. (%)
 Black or African American 65 (22.3) 49 (22.9) 16 (20.5) .90c
 White 174 (59.6) 127 (59.3) 47 (60.3)
 Other or unknown 53 (18.2) 38 (17.8) 15 (19.2)
Ethnicity, No. (%)
 Hispanic or Latino 65 (22.3) 48 (22.4) 17 (21.8) .27c
 Not Hispanic or Latino 214(73.3) 154 (72.0) 60 (76.9)
 Unknown 13 (4.5) 12 (5.6) 1 (1.3)
Preexisting chronic conditions, No. (%)
 None 150 (51.4) 119 (55.6) 31 (39.7) .02c
 Prenatal 36 (12.3) 28(13.1) 8(10.3) .52c
 Lung or airway disease 66 (22.6) 49 (22.9) 17 (21.8) .84c
 Congenital heart disease 35 (12.0) 24(11.2) 11(14.1) .50c
 Gastrointestinal tract 41 (14.0) 32 (15.0) 9(11.5) .46c
 Neurologic 49 (16.8) 36 (16.8) 13 (16.7) .98c
 Other 71 (24.3) 46 (21.5) 25 (32.1) .06c
Night or weekend arrest, No. (%) 141 (48.3) 100 (46.7) 41 (52.6) .38c
Initial cardiac arrest rhythm noted by EMS or hospital, No. (%)
 Asystole 172 (58.9) 126 (58.9) 46 (59.0) .87c
 Bradycardia 19 (6.5) 13 (6.1) 6 (7.7)
 PEA 42 (14.4) 29 (13.6) 13 (16.7)
 Ventricular fibrillation or tachycardia 23 (7.9) 18 (8.4) 5 (6.4)
 Unknown 36 (12.3) 28(13.1) 8 (10.3)
Primary cause of cardiac arrest, No. (%)
 Cardiac 37(12.7) 22 (10.3) 15 (19.2) .01c
 Respiratory 211(72.3) 163 (76.2) 48 (61.5)
 Other 10 (3.4) 4 (1.9) 6 (7.7)
 Unknown 34(11.6) 25 (11.7) 9(11.5)
Cardiac arrest witnessed, No. (%) 108 (37.0) 75 (35.0) 33 (42.3) .51c
Bystander chest compressions, No. (%) 183 (62.7) 135 (63.1) 48 (61.5) .65c
Estimated duration of chest compressions, No. (%)
 ≤15 min 66 (22.6) 48 (22.4) 18 (23.1) .03c
 >15to≤30min 109 (37.3) 89 (41.6) 20 (25.6)
 >30min 106 (36.3) 68 (31.8) 38 (48.7)
 Unable to determine 11 (3.8) 9 (4.2) 2 (2.6)
Total No. of doses of epinephrine administered by EMS and at hospital, No. (%)
 0 19 (6.5) 18 (8.4) 1 (1–3) .02c
 1 35 (12.0) 28(13.1) 7 (9.0)
 2 51 (17.5) 40 (18.7) 11 (14.1)
 3 40 (13.7) 29 (13.6) 11 (14.1)
 4 41 (14.0) 30 (14.0) 11 (14.1)
 >4 76 (26.0) 45 (21.0) 31 (39.7)
 Missing 30 (10.3) 24(11.2) 6 (7.7)
Time from ROSC to TTM initiation, median (IQR), h [No. of participants] 5.8 (5.1–6.5) [292] 5.8(5.1–6.6) [214] 5.9 (5.1–6.4) [78] .74b
Treatment received, No. (%)
 Hypothermia 153 (52.4) 115 (53.7) 38 (48.7) .45c
 Normothermia 139 (47.6) 99 (46.3) 40 (51.3)
Burden of hypotension, median (IQR), % [No. of participants] 0.0 (0.0–13.4) [292] 0.0 (0.0–0.0) [214] 31.0 (16.7–60.0) [78] <.001b
Maximum measured lactate level, median (IQR), mmol/L [No. of participants] 4.7 (2.5–7.8) [238] 3.6(2.0–6.6) [171] 7.5 (4.2–11.5) [67] <.001b
Minimum measured lactate level, median (IQR), mmol/L [No. of participants] 3.7 (1.8–6.7) [238] 3.0 (1.5–5.1) [171] 5.7 (3.2–8.7) [67] <.001b
No medications, No. (%) 110 (37.7) 96 (44.9) 14(17.9) <.001c
No. of vasoactive agents administered, No. (%)
 0 129 (44.2) 111(51.9) 18(23.1) <.001c
 1 80 (27.4) 60 (28.0) 20 (25.6)
 2 70 (24.0) 38 (17.8) 32 (41.0)
 3 13 (4.5) 5 (2.3) 8 (10.3)
Milrinone administered, No. (%) 28 (9.6) 16 (7.5) 12 (15.4) .04c
Corticosteroids administered. No. (%) 39 (13.4) 18 (8.4) 21 (26.9) <.001c
Vasopressin administered, No. (%) 42 (14.4) 25(11.7) 17 (21.8) .03c

Abbreviations: EMS, emergency medical services; IQR, interquartile range; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; TTM, targeted temperature management.

a

Indicates hypotension at 0 to 6 hours. Percentages have been rounded and may not total 100.

b

Calculated using the Wilcoxon rank sum test.

c

Calculated using the χ2 test of no association.